[Multiple actors involved in the Swedish system for pharmaceutical recommendations].

Authors

Maria Palmetun Ekbäck, Kristina Seling

Published in

Lakartidningen. Volume 123. Oct 29, 2026. Epub Oct 29, 2026.

Abstract

The Swedish system for pharmaceutical recommendations is based on multiple actors with clearly complementary roles (authorities, regions, and expert bodies). Four national agencies contribute different perspectives: clinical (the Swedish Medical Products Agency), system/policy (the National Board of Health and Welfare), population (the Public Health Agency of Sweden), and evidence (the Swedish Agency for Health Technology Assessment and Assessment of Social Services), while TLV (the Dental and Pharmaceutical Benefits Agency) is responsible for health economics. Practical prioritisation in clinical practice is mainly carried out by drug and therapeutics committees (for prescription medicines) and the NT Council (for hospital-administered medicines). Overall, the system aims to achieve evidence-based, equitable, and cost-effective use of medicines.

PMID:
42954056
Bibliographic data and abstract were imported from PubMed on 30 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.